Sponsors

Screening for Cryptosporidium/Giardia by EIA

Cryptosporidiosis is routinely diagnosed by microscopic analysis of stool samples using organic dyes or by immunostaining by direct fluorescent antibody, and can be difficult to detect. Similarly, Giardia infection is frequently misdiagnosed, relying on poorly performing antigen-based testing.

Pro-Lab Diagnostics’ Prolisa Cryptosporidium/Giardia enzyme immunoassay (EIA) is a convenient, rapid and easy-to-use method for detecting Cryptosporidium and Giardia lamblia. Supplied in a 96-well test size consisting of detachable stripwells, this manual assay uses monoclonal anti-Cryptosporidium and anti-G. lamblia antibodies to ensure excellent sensitivity and specificity for high-value diagnostic results, and can also be performed on most automated platforms for increased workflow flexibility.

Mark Reed, General Manager of Pro-Lab Diagnostics, commented: “The Cryptosporidium/Giardia EIA is an important part of the Prolisa product range, offering our customers a simple and cost-effective alternative means of testing for cryptosporidiosis and giardiasis, with the back-up support of our team of application experts.”
www.pro-lab.com

Latest Issues

BDIAP Molecular Pathology Study Day

10 Union Street, London, SE1 1SZ
2 March, 2026

Cell & Gene Therapy 2026

Hinxton Hall Conference Centre, Wellcome Genome Campus, Hinxton, CB10 1RQ
9-10 March, 2026

USCAP 115th Annual Meeting

Henry B. González Convention Center, San Antonio, Texas, USA
21-26 March, 2026